Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 9th October 2023
In the ordinary rebalance, the following composition will be implemented effective open 09.10.2023:
ABBOTT LABORATORIES |
ABBVIE INC |
AGILENT TECHNOLOGIES INC |
ALCON INC |
AMGEN INC |
BAYER AG |
BECTON DICKINSON AND CO |
BIOGEN INC |
BRISTOL-MYERS SQUIBB CO |
COLOPLAST AS CLASS B |
CONVATEC GROUP PLC |
COOPER COMPANIES INC |
DANAHER CORP |
DENTSPLY SIRONA INC |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
ESSILORLUXOTTICA |
EXELIXIS INC |
GILEAD SCIENCES INC |
GSK PLC |
HOLOGIC INC |
INCYTE CORP |
IQVIA HOLDINGS INC |
JAZZ PHARMACEUTICALS PLC |
JOHNSON & JOHNSON |
LABORATORY CRP OF AMER HLDGS |
MEDTRONIC PLC |
MERCK & CO. INC. |
NEUROCRINE BIOSCIENCES INC |
NOVARTIS AG |
PFIZER INC |
PRESTIGE CONSUMER HEALTHCARE INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
REGENERON PHARMACEUTICALS |
REVVITY INC |
ROCHE HOLDING AG |
ROYALTY PHARMA PLC- CL A |
SANOFI SA |
SEAGEN INC |
SIEMENS HEALTHINEERS AG |
STERIS PLC |
STRYKER CORP |
THERMO FISHER SCIENTIFIC INC |
UCB SA |
UNITED THERAPEUTICS CORP |
UNITEDHEALTH GROUP INC |
VERALTO CORP |
VERTEX PHARMACEUTICALS INC |
WEST PHARMACEUTICAL SERVICES INC |
ZIMMER BIOMET HOLDINGS INC |